The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I, first-in-human trial of LV305 in patients with advanced or metastatic cancer expressing NY-ESO-1.
 
Neeta Somaiah
Research Funding - Immune Design
 
Matthew Stephen Block
Research Funding - Immune Design; TapImmune Inc.
 
Joseph W. Kim
No Relationships to Disclose
 
Geoffrey Shapiro
Consulting or Advisory Role - Chugai Pharma; G1 Therapeutics; Vertex
Research Funding - AstraZeneca (Inst); Bayer (Inst); Cellceutix (Inst); Covidien (Inst); Cyclacel (Inst); Genentech (Inst); Immune Design (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tensha Therapeutics (Inst); Vertex (Inst)
 
Patrick Hwu
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb; Genentech
 
Joseph Paul Eder
Consulting or Advisory Role - Astellas Pharma
Travel, Accommodations, Expenses - MedImmune
 
Robin Lewis Jones
Honoraria - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Consulting or Advisory Role - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Research Funding - Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); Janssen Research & Development (Inst); MabVax (Inst); Merck Sharp & Dohme (Inst); Morphotek (Inst); Novartis (Inst); PharmaMar (Inst); Threshold Pharmaceuticals (Inst); Ziopharm Oncology (Inst)
Travel, Accommodations, Expenses - Compass Oncology; EMD Serono; Novartis; Pfizer
 
Sacha Gnjatic
Consulting or Advisory Role - Boehringer Ingelheim; Third Rock Ventures
Research Funding - Immune Design; Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Ludwig Institute for Cancer Research
Travel, Accommodations, Expenses - Boehringer Ingelheim
 
Hailing Lu
Employment - Immune Design
Stock and Other Ownership Interests - Immune Design
Research Funding - VentiRx; VentiRx (Inst)
 
Frank James Hsu
Employment - Immune Design; Zyngenia
Leadership - Immune Design; Zyngenia
Stock and Other Ownership Interests - Immune Design; Zyngenia
Patents, Royalties, Other Intellectual Property - Genzyme; Immune Design; Stanford University
Travel, Accommodations, Expenses - Immune Design; Zyngenia
 
Seth Pollack
Research Funding - Immune Design